Skip to content

Hypnosis for Treating Xerostomia Following Radiotherapy in Head & Neck Cancer Patients

Phase 2 Study of Hypnosis for Treating Xerostomia Following Radiotherapy in Head & Neck Cancer Patients

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00408759
Enrollment
10
Registered
2006-12-07
Start date
2006-11-30
Completion date
2006-12-31
Last updated
2006-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Xerostomia

Keywords

xerostomia, hypnosis, dry mouth, radiotherapy, head and neck cancer

Brief summary

xerostomia develops in all patients with head and neck cancer following radiotherapy. it consists one of the main side effects which affects quality of life. currently, there is no standard of care for treating this condition. parasympathomimetic drugs may help but carry significant side effects. hypnosis may affect autonomic function such as salivation, in healthy people.in this study we will explore the efficacy of hypnosis in improving salivation, in the patient population.

Detailed description

10 head and neck cancer patients with xerostomia following radiotherapy will be assessed for severity of xerostomia using questionnares and quantitative salivation tests. patients responsive to citric acid will receive a hypnotic session with specific suggestion for salivation. saliva volume will be assessed pre and post hypnosis. patients will receive a CD with recorded hypnotic session to use freely at home. xerostomia will be assessed using a questionnare one week following hypnosis.

Interventions

BEHAVIORALhypnosis

Sponsors

Bnai Zion Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* radiotherapy for head and neck cancer * xerostomia

Exclusion criteria

* psychiatric illness (present or past)

Design outcomes

Primary

MeasureTime frame
salivaa volume
quality of life related to salivation

Countries

Israel

Contacts

Primary Contactelad schiff
eschiff@email.arizona.edu972482654767
Backup Contactgorge mogilner
eschiff@bezeqint.net97248359359

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026